Thanks @HS2912 , in this case now I agree with you. It seems this trial was just underpowered to say much about DKD if the placebo group had such a large improvement in albuminuria. The high albuminuria subgroup is interesting but at the moment I am grounding my thesis on FSGS and REMAP-CAP.
- Forums
- ASX - By Stock
- Ann: Dimerix Plans for Next Study in Diabetic Kidney Disease
Thanks @HS2912 , in this case now I agree with you. It seems...
-
-
- There are more pages in this discussion • 148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
54.5¢ |
Change
0.015(2.83%) |
Mkt cap ! $299.6M |
Open | High | Low | Value | Volume |
53.0¢ | 54.5¢ | 52.0¢ | $905.8K | 1.698M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8606 | 53.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
54.5¢ | 72714 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8606 | 0.535 |
2 | 210300 | 0.530 |
4 | 47553 | 0.525 |
3 | 82249 | 0.520 |
3 | 145300 | 0.515 |
Price($) | Vol. | No. |
---|---|---|
0.545 | 32714 | 4 |
0.550 | 71490 | 6 |
0.555 | 24240 | 1 |
0.560 | 66593 | 3 |
0.565 | 24240 | 1 |
Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |